<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en" style="background:#f6f6f6!important"> <head> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> <meta name="viewport" content="width=device-width"> <title>PRNJ Push Email - Headlines</title> <style>@font-face{font-family:Montserrat;font-style:normal;font-weight:400;src:local('Montserrat Regular'),local('Montserrat-Regular'),url(https://fonts.gstatic.com/s/montserrat/v10/SKK6Nusyv8QPNMtI4j9J2wsYbbCjybiHxArTLjt7FRU.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:normal;font-weight:400;src:local('Montserrat Regular'),local('Montserrat-Regular'),url(https://fonts.gstatic.com/s/montserrat/v10/gFXtEMCp1m_YzxsBpKl68gsYbbCjybiHxArTLjt7FRU.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:normal;font-weight:400;src:local('Montserrat Regular'),local('Montserrat-Regular'),url(https://fonts.gstatic.com/s/montserrat/v10/zhcz-_WihjSQC0oHJ9TCYAzyDMXhdD8sAj6OAJTFsBI.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@font-face{font-family:Montserrat;font-style:normal;font-weight:500;src:local('Montserrat Medium'),local('Montserrat-Medium'),url(https://fonts.gstatic.com/s/montserrat/v10/BYPM-GE291ZjIXBWrtCweiyNCiQPWMSUbZmR9GEZ2io.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:normal;font-weight:500;src:local('Montserrat Medium'),local('Montserrat-Medium'),url(https://fonts.gstatic.com/s/montserrat/v10/BYPM-GE291ZjIXBWrtCwevfgCb1svrO3-Ym-Rpjvnho.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:normal;font-weight:500;src:local('Montserrat Medium'),local('Montserrat-Medium'),url(https://fonts.gstatic.com/s/montserrat/v10/BYPM-GE291ZjIXBWrtCweteM9fzAXBk846EtUMhet0E.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@font-face{font-family:Montserrat;font-style:normal;font-weight:600;src:local('Montserrat SemiBold'),local('Montserrat-SemiBold'),url(https://fonts.gstatic.com/s/montserrat/v10/q2OIMsAtXEkOulLQVdSl053YFo3oYz9Qj7-_6Ux-KkY.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:normal;font-weight:600;src:local('Montserrat SemiBold'),local('Montserrat-SemiBold'),url(https://fonts.gstatic.com/s/montserrat/v10/q2OIMsAtXEkOulLQVdSl02tASdhiysHpWmctaYEsrdw.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:normal;font-weight:600;src:local('Montserrat SemiBold'),local('Montserrat-SemiBold'),url(https://fonts.gstatic.com/s/montserrat/v10/q2OIMsAtXEkOulLQVdSl03XcDWh-RbO457623Zi1kyw.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@font-face{font-family:Montserrat;font-style:italic;font-weight:400;src:local('Montserrat Italic'),local('Montserrat-Italic'),url(https://fonts.gstatic.com/s/montserrat/v10/-iqwlckIhsmvkx0N6rwPmvgrLsWo7Jk1KvZser0olKY.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:italic;font-weight:400;src:local('Montserrat Italic'),local('Montserrat-Italic'),url(https://fonts.gstatic.com/s/montserrat/v10/-iqwlckIhsmvkx0N6rwPmojoYw3YTyktCCer_ilOlhE.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:italic;font-weight:400;src:local('Montserrat Italic'),local('Montserrat-Italic'),url(https://fonts.gstatic.com/s/montserrat/v10/-iqwlckIhsmvkx0N6rwPmhampu5_7CjHW5spxoeN3Vs.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@font-face{font-family:Montserrat;font-style:italic;font-weight:500;src:local('Montserrat Medium Italic'),local('Montserrat-MediumItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9FtxZpeM_Zh6uJFYM6sEJ7jls.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:italic;font-weight:500;src:local('Montserrat Medium Italic'),local('Montserrat-MediumItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9Ft_zIndX4RYN5BhIaIFu8k_A.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:italic;font-weight:500;src:local('Montserrat Medium Italic'),local('Montserrat-MediumItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9Ft9CODO6R-QMzjsZRstdx6VU.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@font-face{font-family:Montserrat;font-style:italic;font-weight:600;src:local('Montserrat SemiBold Italic'),local('Montserrat-SemiBoldItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9Ft8gif8LsIGoxiaDHvDrXzKs.woff2) format('woff2');unicode-range:U+0102-0103,U+1EA0-1EF9,U+20AB}@font-face{font-family:Montserrat;font-style:italic;font-weight:600;src:local('Montserrat SemiBold Italic'),local('Montserrat-SemiBoldItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9Ft34iWgrNFAiT-cwBwpMBdno.woff2) format('woff2');unicode-range:U+0100-024F,U+1E00-1EFF,U+20A0-20AB,U+20AD-20CF,U+2C60-2C7F,U+A720-A7FF}@font-face{font-family:Montserrat;font-style:italic;font-weight:600;src:local('Montserrat SemiBold Italic'),local('Montserrat-SemiBoldItalic'),url(https://fonts.gstatic.com/s/montserrat/v10/zhwB3-BAdyKDf0geWr9Ft93uLUHnU24AL_1IdxwhTqs.woff2) format('woff2');unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2212,U+2215}@media only screen{html{min-height:100%;background:#f3f3f3}}@media only screen and (max-width:630px){table.body img{width:auto;height:auto}table.body center{min-width:0!important}table.body .container{width:95%!important}table.body .columns{height:auto!important;-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box;padding-left:30px!important;padding-right:30px!important}table.body .columns .columns{padding-left:0!important;padding-right:0!important}th.small-12{display:inline-block!important;width:100%!important}.columns th.small-12{display:block!important;width:100%!important}table.menu{width:100%!important}table.menu td,table.menu th{width:auto!important;display:inline-block!important}table.menu[align=center]{width:auto!important}}</style> </head> <body style="-moz-box-sizing:border-box;-ms-text-size-adjust:100%;-webkit-box-sizing:border-box;-webkit-text-size-adjust:100%;Margin:0;background:#f6f6f6!important;box-sizing:border-box;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;min-width:100%;padding:0;text-align:left;width:100%!important"> <span class="preheader" style="color:#f3f3f3;display:none!important;font-size:1px;line-height:1px;max-height:0;max-width:0;mso-hide:all!important;opacity:0;overflow:hidden;visibility:hidden"></span> <table class="body" style="Margin:0;background:#f6f6f6!important;border-collapse:collapse;border-spacing:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;height:100%;line-height:1.3;margin:0;padding:0;text-align:left;vertical-align:top;width:100%"> <tr style="padding:0;text-align:left;vertical-align:top"> <td class="center" align="center" valign="top" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;hyphens:auto;line-height:1.3;margin:0;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> <center data-parsed="" style="min-width:600px;width:100%"><!--[if mso]><style type="text/css">body, table, table.body, h1, h2, h3, h4, h5, h6, p, td, th, a { font-family: 'Montserrat', Arial, sans-serif!important;}</style><![endif]--><table align="center" class="container float-center" style="Margin:0 auto;background:#fefefe;border-collapse:collapse;border-spacing:0;float:none;margin:0 auto;padding:0;text-align:center;vertical-align:top;width:600px"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;hyphens:auto;line-height:1.3;margin:0;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> <table class="row no-background" style="background:#f6f6f6;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:16px;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left"><table class="spacer" style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td height="24px" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:24px;font-weight:400;hyphens:auto;line-height:24px;margin:0;mso-line-height-rule:exactly;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> </td></tr></tbody></table> <p class="text-center view-in-browser" style="Margin:0;Margin-bottom:10px;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;margin-bottom:0;padding:0;text-align:center"><small style="color:#cacaca;font-size:80%"><a href='http://email.prnewswire.com/wf/click?upn=z3qiKnBCpunqdJkRppsiEbSmnibeutBGHu9PCpp0b6U4Q4ZotzjXnIzJXOhYxAYUATomYP0h0FHE6BC-2F1bSDbYH5WyEQl0yU6S1wF6jUA-2B5K3tiBJXgMnJnimj-2FleypP41tqAHivi3zWpCMUsYK9ndhTcmkwKRxMhu8nZ-2BRSEL4-3D_q1N77mbql2CxsoEfo2fFiZ6dnlev64IGUSa1KT1DDw1MuprZmQ6aap9NY9k0Le75LnIEQiEkJeFErX6yv1GZ9uN6PDMjZM1qzq-2FOu7T3pxlRJnEw1-2BhIfvMWisUKE9rSh-2FdHxz14reof0Q6zSeNFxW-2BP-2FYidBeY7elEUXMqYVQa9CmSHMmU7utO-2B-2BOfyOWdkhqjcgfe1LgPWloIIqKKtqJE8yO7pEsMn7xl9eMLZh0MXF1qmcqZcN5aIBSu36oDCNlD1-2FuWZJ5yP8m2RYqezHFVvBYvuRLz5T7lA9MdviYSuChixUQAagdfo5ACoUX1hEMfXFhLwZLimDftjUr3LdA-3D-3D'style='Margin:0;color:#00607F;font-family:Montserrat,Arial,sans-serif;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left;text-decoration:none'>View in Browser</a></small> </p> </th><th class="expander" style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0!important;text-align:left;visibility:hidden;width:0"></th></tr></table></th> </tr></tbody></table><table class="row sub-header"style="background:#00837E;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:16px;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left"><table class="spacer" style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td height="16px" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;hyphens:auto;line-height:16px;margin:0;mso-line-height-rule:exactly;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> </td></tr></tbody></table> <h4 class="text-center" style="-moz-hyphens:none;-webkit-hyphens:none;Margin:0;Margin-bottom:10px;color:#fff;font-family:Montserrat,Arial,sans-serif;font-size:18px;font-weight:400;hyphens:none;line-height:22px;margin:0;margin-bottom:10px;padding:0;text-align:center;text-transform:uppercase;word-break:none;word-wrap:normal">News From Companion Medical</h4><h5 class="text-center" style="-moz-hyphens:none;-webkit-hyphens:none;Margin:0;Margin-bottom:10px;color:#fff;font-family:Montserrat,Arial,sans-serif;font-size:14px;font-weight:500;hyphens:none;line-height:18px;margin:0;margin-bottom:0;padding:0;text-align:center;word-break:none;word-wrap:normal">Transmitted by PR Newswire for Journalists on <span class="prevent-break" style="display:inline-block">July 19, 2018 12:37 PM EST </span></h5></th><th class="expander" style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0!important;text-align:left;visibility:hidden;width:0"></th></tr></table></th></tr></tbody></table><table class="row header" style="background:#e5f2f3;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:0;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left"> <table class="spacer" style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td height="24px" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:24px;font-weight:400;hyphens:auto;line-height:24px;margin:0;mso-line-height-rule:exactly;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> </td></tr></tbody></table> <h1 style="Margin:0;Margin-bottom:10px;color:#4D4E53;font-family:Montserrat,Arial,sans-serif;font-size:20px;font-weight:500;line-height:28px;margin:0;margin-bottom:0;padding:0;text-align:left;word-wrap:normal">Companion Medical Announces CE Mark of InPen⢠System</h1> <table class="spacer" style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td height="24px" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:24px;font-weight:400;hyphens:auto;line-height:24px;margin:0;mso-line-height-rule:exactly;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> </td></tr></tbody></table> </th><th class="expander" style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0!important;text-align:left;visibility:hidden;width:0"></th></tr></table></th> </tr></tbody></table> <table class="row content" style="background:#fff;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:16px;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left"> <table class="spacer" style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><td height="24px" style="-moz-hyphens:auto;-webkit-hyphens:auto;Margin:0;border-collapse:collapse!important;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:24px;font-weight:400;hyphens:auto;line-height:24px;margin:0;mso-line-height-rule:exactly;padding:0;text-align:left;vertical-align:top;word-wrap:break-word"> </td></tr></tbody></table><p><span class="xn-location">SAN DIEGO</span>, <span class="xn-chron">July 19, 2018</span> /PRNewswire/ -- Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received CE mark for the InPen system, paving the way for launch in key international markets. The InPen system is commercially available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.</p>
<p>"We look forward to introducing more sophisticated smart pen technology with integrated diabetes management tools to people with diabetes in <span class="xn-location">Europe</span>," said Chief Executive Officer <span class="xn-person">Sean Saint</span>. "Our mission is to empower people living with diabetes and their healthcare providers with easy-to-use solutions that improve outcomes at a lower cost. With diabetes, the greatest challenge is knowing how much insulin to take and when to take it. The InPen system gives people with diabetes the tools they need to answer those questions precisely and accurately. Healthcare providers need actionable, reliable data from their insulin pen users, and now finally have that through Insights by InPen, our integrated diabetes management report." </p><th class="expander" style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0!important;text-align:left;visibility:hidden;width:0"></th></tr></table></th></tr></tbody></table><table class="row content" style="background:#fff;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:16px;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left"><center data-parsed="" style="min-width:510px;width:100%"><img src="https://mma.prnewswire.com/media/720747/Companion_Medical_Logo.jpg" alt="" align="center" class="float-center" style="-ms-interpolation-mode:bicubic;Margin:0 auto;clear:both;display:block;float:none;margin:0 auto;max-width:100%;outline:0;text-align:center;text-decoration:none;width:auto"></center></th><th class="expander" style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0!important;text-align:left;visibility:hidden;width:0"></th></tr></table></th></tr></tbody></table><table class="row content" style="background:#fff;border-collapse:collapse;border-spacing:0;display:table;padding:0;position:relative;text-align:left;vertical-align:top;width:100%"><tbody><tr style="padding:0;text-align:left;vertical-align:top"><th class="small-12 large-12 columns first last" style="Margin:0 auto;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0 auto;padding:0;padding-bottom:16px;padding-left:30px;padding-right:30px;text-align:left;width:570px"><table style="border-collapse:collapse;border-spacing:0;padding:0;text-align:left;vertical-align:top;width:100%"><tr style="padding:0;text-align:left;vertical-align:top"><th style="Margin:0;color:#0a0a0a;font-family:Montserrat,Arial,sans-serif;font-size:16px;font-weight:400;line-height:1.3;margin:0;padding:0;text-align:left">
<p>The Insights by InPen report displays aggregated glucose, insulin, and meal data with detailed daily views, enabling providers to monitor glucose control and adherence patterns, identify the causes and effects of key decisions, and make targeted improvements to therapy.</p>
<p>Companion Medical intends to bring the benefits of the InPen system to <span class="xn-location">Europe</span> in 2019. Currently, more than 90% of insulin delivered around the world is administered through pens and syringes. Durable insulin pens are particularly well utilized in <span class="xn-location">Europe</span>, providing an obvious and significant opportunity for InPen. Given that insulin pump therapy comprises less than 10% of US insulin delivery and even less in <span class="xn-location">Europe</span>, Companion Medical's advanced insulin and disease management technology for pen users fulfills a tremendous unmet need. </p>
<p>InPen is available in the U.S. by prescription only. The app is available for download on the Apple® <span class="xn-person">App Store</span> with launch in the Android marketplace expected later this year.</p>
<p>For more information, visit <a href="http://email.prnewswire.com/wf/click?upn=TwIh0OIjG8BOSB67uKqqj0QMA9SxI1apFdGgsZOsJNlJJowDfZaYFimQcE-2BPetqv_q1N77mbql2CxsoEfo2fFiZ6dnlev64IGUSa1KT1DDw1MuprZmQ6aap9NY9k0Le75LnIEQiEkJeFErX6yv1GZ9uN6PDMjZM1qzq-2FOu7T3pxlRJnEw1-2BhIfvMWisUKE9rSh-2FdHxz14reof0Q6zSeNFxW-2BP-2FYidBeY7elEUXMqYVQa9CmSHMmU7utO-2B-2BOfyOWdkoYpBRVaoZGpFe26C1EZV26BXrC-2F34l-2B-2FRGa4CiWVMyTr4G6jylrOci3GGQevzSAMk18biLNsvKEC5tvU-2BGhR2ryGn5dHeu6d63WEACElH-2FRwJuuC0LuyGAAP8eBe5duHS3rFmW3vxMhx6uIZ1lDalw-3D-3D" rel="nofollow" target="_blank">http://www.companionmedical.com</a>.</p>
<p><b>About Companion Medical </b></p>
<p>Companion Medical, Inc. (<a href="http://email.prnewswire.com/wf/click?upn=TwIh0OIjG8BOSB67uKqqj0QMA9SxI1apFdGgsZOsJNlJJowDfZaYFimQcE-2BPetqv_q1N77mbql2CxsoEfo2fFiZ6dnlev64IGUSa1KT1DDw1MuprZmQ6aap9NY9k0Le75LnIEQiEkJeFErX6yv1GZ9uN6PDMjZM1qzq-2FOu7T3pxlRJnEw1-2BhIfvMWisUKE9rSh-2FdHxz14reof0Q6zSeNFxW-2BP-2FYidBeY7elEUXMqYVQa9CmSHMmU7utO-2B-2BOfyOWdkitddq2SZOs7HljXcHw3USETF9K-2FbeCEL1-2Fw9braat-2FAilr-2F7n2OocbTG2VCHUMpcfAIELvl9hGINqamRP4aHMS7jJLtmrog6i0LGnEUelvI-2Fgu5pTEMV4QIbh0fABFS-2FDgP75cikoB6-2FwDp-2Fe-2BmzFA-3D-3D" rel="nofollow" target="_blank">http://www.companionmedical.com</a>) is a privately held company based in <span class="xn-location">San Diego, CA.</span> The company leverages cross-functional engineering expertise, clinical experience and first-hand knowledge of diabetes to develop innovative solutions for diabetes management.</p>
<p>Contact:<br><span class="xn-person">Megan Hakes</span><br>858-522-0252<br><a href="mailto:198910@email4pr.com" rel="nofollow" target="_blank">198910@email4pr.com</a> </p>